AVTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Avalo Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$11.59+0.32 (+2.84%)
Close on Oct 19, 2026
- Market cap
- $505.35M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Avalo Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2026 | Jun 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2026 | Jun 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 26, 2026 | Apr 28, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 10, 2026 | Apr 10, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 23, 2026 | Mar 27, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 23, 2026 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 2, 2025 | Dec 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2025 | Oct 29, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 10, 2025 | Oct 10, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2025 | Oct 1, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2025 | Sep 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 20, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 18, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2025 | Jun 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2025 | May 1, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2025 | Mar 26, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2025 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 1, 2025 | Jan 2, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2024 | Dec 5, 2024 | SEC EDGAR |